Clinical Trial Update: Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sulopenem to ertapenem for complicated intra-abdominal infection has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraabdominalinfections

Drugs mentioned

• ERTAPENEM (ertapenem)
• Sulopenem (sulopenem)

Snippet

Sponsor: Iterum Therapeutics, International Limited | Conditions: Intra Abdominal Infections | Phase 3 | Status: COMPLETED | Results posted: 2020-12-01